Commentaries: Lecanemab: pioneering the way as the first approved drug for Alzheimer’s disease treatment
Crossref DOI link: https://doi.org/10.1007/s00011-023-01788-y
Published Online: 2023-09-08
Published Print: 2023-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhang, Jinwei
Funding for this research was provided by:
The Royal Society UK (IEC\NSFC\201094)
Text and Data Mining valid from 2023-09-01
Version of Record valid from 2023-09-01
Article History
Received: 11 July 2023
Revised: 11 August 2023
Accepted: 17 August 2023
First Online: 8 September 2023
Declarations
:
: None declared.